1.
Farm Hosp
; 39(5): 314-5, 2015 Sep 01.
Article
in Spanish
| MEDLINE
| ID: mdl-26546944
Subject(s)
Fingolimod Hydrochloride/therapeutic use , Immunosuppressive Agents/therapeutic use , Multiple Sclerosis, Relapsing-Remitting/drug therapy , Natalizumab/therapeutic use , Adult , Female , Fingolimod Hydrochloride/administration & dosage , Fingolimod Hydrochloride/adverse effects , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/adverse effects , Magnetic Resonance Imaging , Male , Middle Aged , Multiple Sclerosis, Relapsing-Remitting/diagnostic imaging , Natalizumab/administration & dosage , Natalizumab/adverse effects
2.
Farm. hosp
; 39(5): 314-315, sept.-oct. 2015.
Article
in Spanish
| IBECS
| ID: ibc-143214
ABSTRACT
No disponible